Standard BioTools Inc expected to post a loss of 12 cents a share - Earnings Preview

Standard BioTools

07/05/2024 03:07

* Standard BioTools Inc  LAB.OQ   LAB.O  is expected
to report
resultson May 8 for the period ending March 31 2024
    * The South San Francisco California-based  company is
expected to
report revenue of $46.006 million, according to the mean
estimate from 3 analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Standard BioTools Inc is
for a
loss of 12 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Standard
BioTools
Inc is $3.50​, above​ its last closing price of $2.48. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023              -0.13      -0.25     Missed  -92.3
 Sep. 30 2023  -0.12       -0.12      -0.27     Missed  -125
 Jun. 30 2023  -0.21       -0.21      -0.22     Missed  -4.8​
 ​​                                   -0.26             
                                      -0.37             ​
                                      -0.82             
                                      -0.99             
 This summary was machine generated May 7 at 02:07 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)